DILI | Visikol

HUREL™ Micro Liver Metabolite ID Services

Carol Tomaszewski2023-04-06T07:24:52-05:00Tags: DILI, HUREL, HUREL Products, HUREL Services, Metabolite ID|

The HUREL Micro Liver platform continues to be the gold standard advanced cell culture model for use in liver [...]

Visikol to present at SELECTBIO’s December 2021 Conference

Carol Tomaszewski2021-11-05T15:34:56-05:00Tags: Conference, DILI, in vitro, Liver, Liver in vitro, NAFLD, NASH|

Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]

HUREL Models Assist in the Evaluation of Hepatoxicity

Carol Tomaszewski2021-10-25T09:07:40-05:00Tags: DILI, drug discovery, hepatoxicity, HUREL, Micro Livers|

Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]